An investigation for investors in Nektar Therapeutics (NASDAQ: NKTR) shares over potential securities laws violations by Nektar Therapeutics was announced.
San Diego, CA -- (SBWIRE) -- 10/18/2018 -- Nektar Therapeutics is under investigation concerning possible violations of securities laws violations in connection with certain financial statements.
Investors who purchased shares of Nektar Therapeutics (NASDAQ: NKTR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Nektar Therapeutics regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Francisco, CA based Nektar Therapeutics, a research-based biopharmaceutical company, discovers and develops drug candidates for cancer, auto-immune disease, and chronic pain in the United States.
On October 1, 2018, Plainview LLC published a report raising questions about Nektar Therapeutics' claims concerning its clinical stage drug, NKTR-214, a cytokine immunostimulatory therapy that is in Phase I/II to treat cancer, and its ability to effectively treat cancer.
Those who purchased shares of Nektar Therapeutics (NASDAQ: NKTR) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.